These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31895498)

  • 1. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.
    Harati-Sadegh M; Kohan L; Teimoori B; Mehrabani M; Salimi S
    J Biomed Sci; 2019 Nov; 26(1):92. PubMed ID: 31703578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
    Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma.
    Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z
    IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
    Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
    Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
    Maruei-Milan R; Heidari Z; Salimi S
    J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus.
    Macedo JMB; Silva AL; Pinto AC; Landeira LFL; Portari EA; Santos-Rebouças CB; Klumb EM
    Adv Rheumatol; 2023 Aug; 63(1):43. PubMed ID: 37605254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
    Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
    Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms, mRNA expression of p53 and p21 with chronic benzene poisoning in a chinese occupational population.
    Sun P; Qiu Y; Zhang Z; Wan J; Wang T; Jin X; Lan Q; Rothman N; Xia ZL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1821-8. PubMed ID: 19505915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer.
    Jeong S; Lee J; Kim D; Seol MY; Lee WK; Jeong JJ; Nam KH; Jung SG; Shin DY; Lee EJ; Chung WY; Jo YS
    Medicine (Baltimore); 2016 Jan; 95(4):e2592. PubMed ID: 26825907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
    Su X; Lin LW; Weng JL; Chen SW; Yang XH; Zhou DL; Long YK; Shao Q; Ye ZL; Peng JL; Deng L; He CY; Yang AK
    Cancer Biomark; 2019; 26(4):461-470. PubMed ID: 31658048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.